Item Infomation
Title: | Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
Authors: | Marius, Trøseid José R., Arribas Lambert, Assoumou |
Issue Date: | 2023 |
Publisher: | Springer |
Abstract: | Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. |
Description: | CC BY |
URI: | https://link.springer.com/article/10.1186/s13054-022-04205-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 |
Appears in Collections | OER- Y học- Điều dưỡng |
ABSTRACTS VIEWS
25
FULLTEXT VIEWS
33
Files in This Item: